id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1992-S-0039-0013,FDA,FDA-1992-S-0039,"CDER to the Division of Dockets Management Investigational New Drug Applications, New Drug Applications, Biologics Licensing Applications, Abbreviated New Drug Applications, Master Files, and Annual Reports, Memo 34 - Memorandum",Supporting & Related Material,Memorandum,2007-09-13T04:00:00Z,2007,9,,,2012-11-16T22:46:28Z,,0,0,090000648052892d